These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 1379745)

  • 21. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.
    Dai Z; Pendergast AM
    Genes Dev; 1995 Nov; 9(21):2569-82. PubMed ID: 7590236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.
    Gishizky ML; Cortez D; Pendergast AM
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10889-93. PubMed ID: 7479904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
    Jackson PK; Paskind M; Baltimore D
    Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the Abl tyrosine kinase in vivo by Src homology 3 domains from the Src homology 2/Src homology 3 adaptor Nck.
    Smith JM; Katz S; Mayer BJ
    J Biol Chem; 1999 Sep; 274(39):27956-62. PubMed ID: 10488144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
    Pendergast AM; Quilliam LA; Cripe LD; Bassing CH; Dai Z; Li N; Batzer A; Rabun KM; Der CJ; Schlessinger J
    Cell; 1993 Oct; 75(1):175-85. PubMed ID: 8402896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SH3 domains specifically regulate kinase activity of expressed Src family proteins.
    Abrams CS; Zhao W
    J Biol Chem; 1995 Jan; 270(1):333-9. PubMed ID: 7529230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
    Hjermstad SJ; Briggs SD; Smithgall TE
    Biochemistry; 1993 Oct; 32(39):10519-25. PubMed ID: 7691175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
    Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries.
    Rickles RJ; Botfield MC; Weng Z; Taylor JA; Green OM; Brugge JS; Zoller MJ
    EMBO J; 1994 Dec; 13(23):5598-604. PubMed ID: 7988556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Abl tyrosine kinase binds and phosphorylates phospholipid scramblase 1.
    Sun J; Zhao J; Schwartz MA; Wang JY; Wiedmer T; Sims PJ
    J Biol Chem; 2001 Aug; 276(31):28984-90. PubMed ID: 11390389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Slap negatively regulates Src mitogenic function but does not revert Src-induced cell morphology changes.
    Manes G; Bello P; Roche S
    Mol Cell Biol; 2000 May; 20(10):3396-406. PubMed ID: 10779329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An activating mutation in the ATP binding site of the ABL kinase domain.
    Allen PB; Wiedemann LM
    J Biol Chem; 1996 Aug; 271(32):19585-91. PubMed ID: 8702653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein.
    Zhu J; Shore SK
    Mol Cell Biol; 1996 Dec; 16(12):7054-62. PubMed ID: 8943360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains.
    Stanglmaier M; Warmuth M; Kleinlein I; Reis S; Hallek M
    Leukemia; 2003 Feb; 17(2):283-9. PubMed ID: 12592324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.
    Glover RT; Angiolieri M; Kelly S; Monaghan DT; Wang JY; Smithgall TE; Buller AL
    J Biol Chem; 2000 Apr; 275(17):12725-9. PubMed ID: 10777567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular features of the viral and cellular Src kinases involved in interactions with the GTPase-activating protein.
    Brott BK; Decker S; O'Brien MC; Jove R
    Mol Cell Biol; 1991 Oct; 11(10):5059-67. PubMed ID: 1717825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response.
    Cao C; Leng Y; Li C; Kufe D
    J Biol Chem; 2003 Apr; 278(15):12961-7. PubMed ID: 12569093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.